Home › Funds › Tarbox Family Office, Inc. › ABT

Tarbox Family Office, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Tarbox Family Office, Inc. reported holding 51,501 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 0.72% of its reported portfolio and ranking #21 among its reported holdings. Tarbox Family Office, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.50K sh
Reported value held$5.09M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tarbox Family Office, Inc.'s ABT position evolved

Tarbox Family Office, Inc. first disclosed a stake in ABT in Q3 2023 at 50,740 shares (US$4.9M). The position peaked in Q2 2025 at 52,187 shares, worth US$7.1M. Across 13 filings, Tarbox Family Office, Inc. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 51,501 shares valued at US$5.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 50.74K $4.91M New
Q4 2023 44.99K $4.95M Reduce
Q1 2024 50.74K $5.77M Add
Q2 2024 50.74K $5.27M Hold
Q3 2024 52.19K $5.95M Add
Q4 2024 52.19K $5.90M Hold
Q1 2025 52.19K $6.92M Hold
Q2 2025 52.19K $7.10M Hold
Q3 2025 52.19K $6.99M Hold
Q4 2025 52.15K $6.53M Hold
Q1 2026 51.50K $5.29M Reduce
Q2 2026 51.50K $4.67M Hold
Q3 2026 51.50K $5.09M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Tarbox Family Office, Inc. held ABT?

Tarbox Family Office, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tarbox Family Office, Inc.'s current position in ABT?

As of Q3 2026, Tarbox Family Office, Inc. holds 51.50K shares of ABT (ABBOTT LABORATORIES), valued at $5.09M, representing 0.72% of its reported portfolio and ranking #21.

Has Tarbox Family Office, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Tarbox Family Office, Inc. held unchanged its position in ABT. The position peaked in Q2 2025 at 52.19K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.